Condition
Indications for a Total Hip Prosthesis
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Ceramiconceramic Total Hip Replacement Versus Metalonmetal Hip Resurfacing
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT00285948Not ApplicableCompletedPrimary
Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active Patient
NCT00285129Not ApplicableCompletedPrimary
Primary Ceramic-on-Ceramic Total Hip Replacement Versus Metal-on-Metal Hip Resurfacing in Young Active Patients
Showing all 2 trials
Research Network
Common Treatments
- Ceramiconceramic Total Hip Replacement Versus Metalonmetal Hip Resurfacing1
- Primary Birmingham Hip Resurfacing Arthroplasty Using A Metalonmetal Couple1
Active Sponsors
- University Hospital, Ghent2
Top Investigators
University Hospital, Ghent